Quote History Quoted:
Thank you...
I cannot find hardly any info on these products in the "wild"...
View Quote View All Quotes
View All Quotes
Quote History Quoted:
Quoted:
Quoted:
Thanks for everyone's input...
My financial advisor wants to use these investment vehicles as a hedge against market loss.
The Cole II pays a 5.73% dividend and the Cole V pays a 5.97% dividend.
Both Coles charge a 10% front-end buy in. With a one year hold, 95% at two years and three years for a 100% redemption.
I am about 2-3 years from retirement and these are recommended to be about 20% of my portfolio.
Is this a good idea?
Thanks...
ETA...What did FINRA rule 15-02 do?
Thanks again...
Place holder for tomorrow when I can give you the skinny.
Thank you...
I cannot find hardly any info on these products in the "wild"...
ok im back....
Yeah you won't find much info about them because they aren't publicly traded. You can however find a lot of info on them just reading through the prospectus.
anyhow without giving advice, II looks like it's in office buildings, office parks, dist hubs, mfg facilities etc, where as V seems to be in the retail store front sector.
Click here for some info on COLE the company, and what they been up to
Also, those distributions aren't exactly anything to be exciting about.
You also need to see if you are buying the T share or A share, the comp to the advisor is the same, one has it upfront the other is spread over a few years. either way the total is the same, but one will look worse on the statement than the other, now we get started on 15-02
15-02, is a a little odd, the best way I can describe it is that imagine if you bought a house and there was a realtor involved and you paid them 10k dollars. Now imagine when you went to get the house appraised the appraiser gave you a value of your home but backed out the realtor fee you paid 5 years ago.
What 15-02 was suppose to do was to make 40 act private investments transparent on the fees. Which it did, but the parameters in which they allow you to mark the investment to market doesn't make much sense, considering it's not publicly traded.
20% doesn;t tell us much with out knowing what else you have in there.
Also, what firm is this guy with? It's a little odd that his firm's research dept is recommending them.